News
News
- Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
11/19/2019 / 17:14 - GlobeNewswire - Ovid Therapeutics Appoints Jason Tardio as Chief Commercial Officer
11/18/2019 / 22:05 - GlobeNewswire - Immutep Announces European Patent Grant for LAG525 Antibody
11/14/2019 / 14:00 - GlobeNewswire - ROSEN, A LEADING GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against Novartis AG – NVS
11/10/2019 / 02:34 - GlobeNewswire - Genmab Announces Financial Results for the First Nine Months of 2019
11/06/2019 / 17:01 - GlobeNewswire - Evelo Biosciences Announces Further Positive Interim Phase 1b Clinical Data in Psoriasis and Reports Third Quarter 2019 Financial Results
11/05/2019 / 13:00 - GlobeNewswire - David Eatwell to Retire as Chief Financial Officer of Genmab
10/30/2019 / 21:31 - GlobeNewswire - Vectura Group appoints New Chief Executive Officer
10/29/2019 / 12:00 - GlobeNewswire - Biological Drugs | Global Market Analysis & Forecast, 2017-2025 - Complexity in the Manufacturing Process is Restraining Growth
10/23/2019 / 12:30 - GlobeNewswire - Global Lymphopenia Therapeutics Market Report 2019-2023 with Sales Data for Acquired Lymphopenia & Inherited Lymphopenia Products
10/21/2019 / 10:50 - GlobeNewswire
Real-time